The European Medicines Agency has announced that user acceptance testing of the new web-based electronic application form (eAF) for submitting variations to EU centralized drug approvals has been postponed to allow further improvements to be made and to give stakeholders more time to plan for the new system.
User acceptance testing (UAT) for the variations eAF was originally scheduled to begin this month, but is now expected to...